Aptamer Sciences Inc (KOSDAQ:291650)
1,109.00
-69.00 (-5.86%)
At close: Jan 29, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 44.65 billion as of January 30, 2026. Its market cap has increased by 32.36% in one year.
Market Cap
44.65B
Enterprise Value
35.17B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,109.00
Market Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 44.65B, a decrease of -81.00%. That is a compound annual growth rate of -26.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 45.93B | 50.53% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 74.62B |
| Ark Solutions | 68.91B |
| MOA Life Plus | 68.67B |
| SunBio,Inc. | 68.04B |
| EyeGene | 67.22B |
| NGeneBio | 50.45B |
| J2KBIO | 49.65B |
| SCM Lifescience | 36.42B |